July 2025

Source: PharmaVoice A new bill led by two independent senators seeks to ban direct-to-consumer (DTC) pharmaceutical advertising, arguing that promotions drive up drug costs and mislead patients. While some support the move as a step toward transparency, critics claim it could limit patient awareness and hinder innovation in healthcare marketing. Read more…